nodes	percent_of_prediction	percent_of_DWPC	metapath
Polythiazide—Hyperuricaemia—Chlorambucil—testicular cancer	0.025	0.025	CcSEcCtD
Polythiazide—Blood uric acid increased—Chlorambucil—testicular cancer	0.0236	0.0236	CcSEcCtD
Polythiazide—Vasculitis—Ifosfamide—testicular cancer	0.0157	0.0157	CcSEcCtD
Polythiazide—Aplastic anaemia—Dactinomycin—testicular cancer	0.0157	0.0157	CcSEcCtD
Polythiazide—Hyperuricaemia—Cisplatin—testicular cancer	0.0143	0.0143	CcSEcCtD
Polythiazide—Blood uric acid increased—Cisplatin—testicular cancer	0.0135	0.0135	CcSEcCtD
Polythiazide—Hyperuricaemia—Etoposide—testicular cancer	0.0131	0.0131	CcSEcCtD
Polythiazide—Jaundice—Chlorambucil—testicular cancer	0.0126	0.0126	CcSEcCtD
Polythiazide—Blood uric acid increased—Etoposide—testicular cancer	0.0123	0.0123	CcSEcCtD
Polythiazide—Agranulocytosis—Vinblastine—testicular cancer	0.0111	0.0111	CcSEcCtD
Polythiazide—Pancreatitis—Ifosfamide—testicular cancer	0.00943	0.00943	CcSEcCtD
Polythiazide—Agitation—Chlorambucil—testicular cancer	0.00931	0.00931	CcSEcCtD
Polythiazide—Leukopenia—Chlorambucil—testicular cancer	0.00907	0.00907	CcSEcCtD
Polythiazide—Orthostatic hypotension—Cisplatin—testicular cancer	0.00877	0.00877	CcSEcCtD
Polythiazide—Agranulocytosis—Dactinomycin—testicular cancer	0.00874	0.00874	CcSEcCtD
Polythiazide—Hyperglycaemia—Ifosfamide—testicular cancer	0.00868	0.00868	CcSEcCtD
Polythiazide—Cramp muscle—Cisplatin—testicular cancer	0.00864	0.00864	CcSEcCtD
Polythiazide—Glycosuria—Epirubicin—testicular cancer	0.00838	0.00838	CcSEcCtD
Polythiazide—Vertigo—Vinblastine—testicular cancer	0.00834	0.00834	CcSEcCtD
Polythiazide—Leukopenia—Vinblastine—testicular cancer	0.00831	0.00831	CcSEcCtD
Polythiazide—Pancreatitis—Cisplatin—testicular cancer	0.00813	0.00813	CcSEcCtD
Polythiazide—Thrombocytopenia—Chlorambucil—testicular cancer	0.0081	0.0081	CcSEcCtD
Polythiazide—Agranulocytosis—Ifosfamide—testicular cancer	0.00801	0.00801	CcSEcCtD
Polythiazide—Cramp muscle—Etoposide—testicular cancer	0.00792	0.00792	CcSEcCtD
Polythiazide—Anorexia—Chlorambucil—testicular cancer	0.00788	0.00788	CcSEcCtD
Polythiazide—Hyperuricaemia—Methotrexate—testicular cancer	0.00782	0.00782	CcSEcCtD
Polythiazide—Glycosuria—Doxorubicin—testicular cancer	0.00775	0.00775	CcSEcCtD
Polythiazide—Jaundice cholestatic—Epirubicin—testicular cancer	0.00773	0.00773	CcSEcCtD
Polythiazide—Vasculitis—Methotrexate—testicular cancer	0.00743	0.00743	CcSEcCtD
Polythiazide—Thrombocytopenia—Vinblastine—testicular cancer	0.00742	0.00742	CcSEcCtD
Polythiazide—Blood uric acid increased—Methotrexate—testicular cancer	0.00739	0.00739	CcSEcCtD
Polythiazide—Hyperuricaemia—Epirubicin—testicular cancer	0.00732	0.00732	CcSEcCtD
Polythiazide—Anorexia—Vinblastine—testicular cancer	0.00723	0.00723	CcSEcCtD
Polythiazide—Decreased appetite—Chlorambucil—testicular cancer	0.00719	0.00719	CcSEcCtD
Polythiazide—Jaundice cholestatic—Doxorubicin—testicular cancer	0.00715	0.00715	CcSEcCtD
Polythiazide—Leukopenia—Bleomycin—testicular cancer	0.00702	0.00702	CcSEcCtD
Polythiazide—Blood uric acid increased—Epirubicin—testicular cancer	0.00691	0.00691	CcSEcCtD
Polythiazide—Aplastic anaemia—Methotrexate—testicular cancer	0.00681	0.00681	CcSEcCtD
Polythiazide—Paraesthesia—Vinblastine—testicular cancer	0.00681	0.00681	CcSEcCtD
Polythiazide—Hyperuricaemia—Doxorubicin—testicular cancer	0.00677	0.00677	CcSEcCtD
Polythiazide—Jaundice—Etoposide—testicular cancer	0.0066	0.0066	CcSEcCtD
Polythiazide—Decreased appetite—Vinblastine—testicular cancer	0.00659	0.00659	CcSEcCtD
Polythiazide—Urticaria—Chlorambucil—testicular cancer	0.00657	0.00657	CcSEcCtD
Polythiazide—Leukopenia—Dactinomycin—testicular cancer	0.00655	0.00655	CcSEcCtD
Polythiazide—Constipation—Vinblastine—testicular cancer	0.00648	0.00648	CcSEcCtD
Polythiazide—Blood uric acid increased—Doxorubicin—testicular cancer	0.0064	0.0064	CcSEcCtD
Polythiazide—Aplastic anaemia—Epirubicin—testicular cancer	0.00637	0.00637	CcSEcCtD
Polythiazide—Agranulocytosis—Etoposide—testicular cancer	0.00632	0.00632	CcSEcCtD
Polythiazide—Thrombocytopenia—Bleomycin—testicular cancer	0.00627	0.00627	CcSEcCtD
Polythiazide—Agitation—Ifosfamide—testicular cancer	0.00616	0.00616	CcSEcCtD
Polythiazide—Anorexia—Bleomycin—testicular cancer	0.0061	0.0061	CcSEcCtD
Polythiazide—Hypersensitivity—Chlorambucil—testicular cancer	0.00609	0.00609	CcSEcCtD
Polythiazide—Vertigo—Ifosfamide—testicular cancer	0.00602	0.00602	CcSEcCtD
Polythiazide—Leukopenia—Ifosfamide—testicular cancer	0.006	0.006	CcSEcCtD
Polythiazide—Photosensitivity—Methotrexate—testicular cancer	0.006	0.006	CcSEcCtD
Polythiazide—Asthenia—Chlorambucil—testicular cancer	0.00593	0.00593	CcSEcCtD
Polythiazide—Aplastic anaemia—Doxorubicin—testicular cancer	0.0059	0.0059	CcSEcCtD
Polythiazide—Thrombocytopenia—Dactinomycin—testicular cancer	0.00585	0.00585	CcSEcCtD
Polythiazide—Paraesthesia—Bleomycin—testicular cancer	0.00575	0.00575	CcSEcCtD
Polythiazide—Anorexia—Dactinomycin—testicular cancer	0.00569	0.00569	CcSEcCtD
Polythiazide—Diarrhoea—Chlorambucil—testicular cancer	0.00566	0.00566	CcSEcCtD
Polythiazide—Photosensitivity—Epirubicin—testicular cancer	0.00561	0.00561	CcSEcCtD
Polythiazide—Hypersensitivity—Vinblastine—testicular cancer	0.00558	0.00558	CcSEcCtD
Polythiazide—Decreased appetite—Bleomycin—testicular cancer	0.00557	0.00557	CcSEcCtD
Polythiazide—Muscle spasms—Cisplatin—testicular cancer	0.00556	0.00556	CcSEcCtD
Polythiazide—Vascular purpura—Epirubicin—testicular cancer	0.00551	0.00551	CcSEcCtD
Polythiazide—Asthenia—Vinblastine—testicular cancer	0.00544	0.00544	CcSEcCtD
Polythiazide—Thrombocytopenia—Ifosfamide—testicular cancer	0.00536	0.00536	CcSEcCtD
Polythiazide—Vomiting—Chlorambucil—testicular cancer	0.00526	0.00526	CcSEcCtD
Polythiazide—Anorexia—Ifosfamide—testicular cancer	0.00522	0.00522	CcSEcCtD
Polythiazide—Photosensitivity—Doxorubicin—testicular cancer	0.00519	0.00519	CcSEcCtD
Polythiazide—Decreased appetite—Dactinomycin—testicular cancer	0.00519	0.00519	CcSEcCtD
Polythiazide—Diarrhoea—Vinblastine—testicular cancer	0.00519	0.00519	CcSEcCtD
Polythiazide—Leukopenia—Cisplatin—testicular cancer	0.00517	0.00517	CcSEcCtD
Polythiazide—Purpura—Epirubicin—testicular cancer	0.00511	0.00511	CcSEcCtD
Polythiazide—Vascular purpura—Doxorubicin—testicular cancer	0.0051	0.0051	CcSEcCtD
Polythiazide—Muscle spasms—Etoposide—testicular cancer	0.00509	0.00509	CcSEcCtD
Polythiazide—Urticaria—Bleomycin—testicular cancer	0.00509	0.00509	CcSEcCtD
Polythiazide—Dizziness—Vinblastine—testicular cancer	0.00501	0.00501	CcSEcCtD
Polythiazide—Nausea—Chlorambucil—testicular cancer	0.00491	0.00491	CcSEcCtD
Polythiazide—Paraesthesia—Ifosfamide—testicular cancer	0.00491	0.00491	CcSEcCtD
Polythiazide—Vomiting—Vinblastine—testicular cancer	0.00482	0.00482	CcSEcCtD
Polythiazide—Vertigo—Etoposide—testicular cancer	0.00476	0.00476	CcSEcCtD
Polythiazide—Decreased appetite—Ifosfamide—testicular cancer	0.00476	0.00476	CcSEcCtD
Polythiazide—Headache—Vinblastine—testicular cancer	0.00475	0.00475	CcSEcCtD
Polythiazide—Leukopenia—Etoposide—testicular cancer	0.00474	0.00474	CcSEcCtD
Polythiazide—Purpura—Doxorubicin—testicular cancer	0.00473	0.00473	CcSEcCtD
Polythiazide—Hypersensitivity—Bleomycin—testicular cancer	0.00472	0.00472	CcSEcCtD
Polythiazide—Constipation—Ifosfamide—testicular cancer	0.00468	0.00468	CcSEcCtD
Polythiazide—Thrombocytopenia—Cisplatin—testicular cancer	0.00462	0.00462	CcSEcCtD
Polythiazide—Asthenia—Bleomycin—testicular cancer	0.00459	0.00459	CcSEcCtD
Polythiazide—Nausea—Vinblastine—testicular cancer	0.0045	0.0045	CcSEcCtD
Polythiazide—Orthostatic hypotension—Epirubicin—testicular cancer	0.0045	0.0045	CcSEcCtD
Polythiazide—Anorexia—Cisplatin—testicular cancer	0.0045	0.0045	CcSEcCtD
Polythiazide—Pancreatitis—Methotrexate—testicular cancer	0.00446	0.00446	CcSEcCtD
Polythiazide—Hypersensitivity—Dactinomycin—testicular cancer	0.0044	0.0044	CcSEcCtD
Polythiazide—Urticaria—Ifosfamide—testicular cancer	0.00435	0.00435	CcSEcCtD
Polythiazide—Asthenia—Dactinomycin—testicular cancer	0.00428	0.00428	CcSEcCtD
Polythiazide—Paraesthesia—Cisplatin—testicular cancer	0.00424	0.00424	CcSEcCtD
Polythiazide—Thrombocytopenia—Etoposide—testicular cancer	0.00423	0.00423	CcSEcCtD
Polythiazide—Pancreatitis—Epirubicin—testicular cancer	0.00418	0.00418	CcSEcCtD
Polythiazide—Orthostatic hypotension—Doxorubicin—testicular cancer	0.00417	0.00417	CcSEcCtD
Polythiazide—Photosensitivity reaction—Methotrexate—testicular cancer	0.00415	0.00415	CcSEcCtD
Polythiazide—Anorexia—Etoposide—testicular cancer	0.00412	0.00412	CcSEcCtD
Polythiazide—Decreased appetite—Cisplatin—testicular cancer	0.0041	0.0041	CcSEcCtD
Polythiazide—Diarrhoea—Dactinomycin—testicular cancer	0.00409	0.00409	CcSEcCtD
Polythiazide—Vomiting—Bleomycin—testicular cancer	0.00407	0.00407	CcSEcCtD
Polythiazide—Rash—Bleomycin—testicular cancer	0.00404	0.00404	CcSEcCtD
Polythiazide—Dermatitis—Bleomycin—testicular cancer	0.00403	0.00403	CcSEcCtD
Polythiazide—Hypersensitivity—Ifosfamide—testicular cancer	0.00403	0.00403	CcSEcCtD
Polythiazide—Asthenia—Ifosfamide—testicular cancer	0.00393	0.00393	CcSEcCtD
Polythiazide—Photosensitivity reaction—Epirubicin—testicular cancer	0.00389	0.00389	CcSEcCtD
Polythiazide—Paraesthesia—Etoposide—testicular cancer	0.00388	0.00388	CcSEcCtD
Polythiazide—Pancreatitis—Doxorubicin—testicular cancer	0.00386	0.00386	CcSEcCtD
Polythiazide—Hyperglycaemia—Epirubicin—testicular cancer	0.00384	0.00384	CcSEcCtD
Polythiazide—Nausea—Bleomycin—testicular cancer	0.0038	0.0038	CcSEcCtD
Polythiazide—Vomiting—Dactinomycin—testicular cancer	0.0038	0.0038	CcSEcCtD
Polythiazide—Agranulocytosis—Methotrexate—testicular cancer	0.00379	0.00379	CcSEcCtD
Polythiazide—Rash—Dactinomycin—testicular cancer	0.00376	0.00376	CcSEcCtD
Polythiazide—Decreased appetite—Etoposide—testicular cancer	0.00376	0.00376	CcSEcCtD
Polythiazide—Diarrhoea—Ifosfamide—testicular cancer	0.00374	0.00374	CcSEcCtD
Polythiazide—Jaundice—Epirubicin—testicular cancer	0.0037	0.0037	CcSEcCtD
Polythiazide—Constipation—Etoposide—testicular cancer	0.0037	0.0037	CcSEcCtD
Polythiazide—Dizziness—Ifosfamide—testicular cancer	0.00362	0.00362	CcSEcCtD
Polythiazide—Photosensitivity reaction—Doxorubicin—testicular cancer	0.0036	0.0036	CcSEcCtD
Polythiazide—Hyperglycaemia—Doxorubicin—testicular cancer	0.00356	0.00356	CcSEcCtD
Polythiazide—Nausea—Dactinomycin—testicular cancer	0.00355	0.00355	CcSEcCtD
Polythiazide—Agranulocytosis—Epirubicin—testicular cancer	0.00354	0.00354	CcSEcCtD
Polythiazide—Vomiting—Ifosfamide—testicular cancer	0.00348	0.00348	CcSEcCtD
Polythiazide—Hypersensitivity—Cisplatin—testicular cancer	0.00348	0.00348	CcSEcCtD
Polythiazide—Rash—Ifosfamide—testicular cancer	0.00345	0.00345	CcSEcCtD
Polythiazide—Dermatitis—Ifosfamide—testicular cancer	0.00345	0.00345	CcSEcCtD
Polythiazide—Urticaria—Etoposide—testicular cancer	0.00343	0.00343	CcSEcCtD
Polythiazide—Jaundice—Doxorubicin—testicular cancer	0.00343	0.00343	CcSEcCtD
Polythiazide—Asthenia—Cisplatin—testicular cancer	0.00338	0.00338	CcSEcCtD
Polythiazide—Agranulocytosis—Doxorubicin—testicular cancer	0.00328	0.00328	CcSEcCtD
Polythiazide—Nausea—Ifosfamide—testicular cancer	0.00325	0.00325	CcSEcCtD
Polythiazide—Diarrhoea—Cisplatin—testicular cancer	0.00323	0.00323	CcSEcCtD
Polythiazide—Hypersensitivity—Etoposide—testicular cancer	0.00318	0.00318	CcSEcCtD
Polythiazide—Asthenia—Etoposide—testicular cancer	0.0031	0.0031	CcSEcCtD
Polythiazide—Vomiting—Cisplatin—testicular cancer	0.003	0.003	CcSEcCtD
Polythiazide—Rash—Cisplatin—testicular cancer	0.00297	0.00297	CcSEcCtD
Polythiazide—Dermatitis—Cisplatin—testicular cancer	0.00297	0.00297	CcSEcCtD
Polythiazide—Diarrhoea—Etoposide—testicular cancer	0.00296	0.00296	CcSEcCtD
Polythiazide—Dizziness—Etoposide—testicular cancer	0.00286	0.00286	CcSEcCtD
Polythiazide—Muscle spasms—Epirubicin—testicular cancer	0.00285	0.00285	CcSEcCtD
Polythiazide—Vertigo—Methotrexate—testicular cancer	0.00285	0.00285	CcSEcCtD
Polythiazide—Leukopenia—Methotrexate—testicular cancer	0.00284	0.00284	CcSEcCtD
Polythiazide—Nausea—Cisplatin—testicular cancer	0.0028	0.0028	CcSEcCtD
Polythiazide—Vomiting—Etoposide—testicular cancer	0.00275	0.00275	CcSEcCtD
Polythiazide—Agitation—Epirubicin—testicular cancer	0.00273	0.00273	CcSEcCtD
Polythiazide—Rash—Etoposide—testicular cancer	0.00272	0.00272	CcSEcCtD
Polythiazide—Dermatitis—Etoposide—testicular cancer	0.00272	0.00272	CcSEcCtD
Polythiazide—Headache—Etoposide—testicular cancer	0.00271	0.00271	CcSEcCtD
Polythiazide—Vertigo—Epirubicin—testicular cancer	0.00267	0.00267	CcSEcCtD
Polythiazide—Leukopenia—Epirubicin—testicular cancer	0.00266	0.00266	CcSEcCtD
Polythiazide—Muscle spasms—Doxorubicin—testicular cancer	0.00264	0.00264	CcSEcCtD
Polythiazide—Nausea—Etoposide—testicular cancer	0.00257	0.00257	CcSEcCtD
Polythiazide—Thrombocytopenia—Methotrexate—testicular cancer	0.00253	0.00253	CcSEcCtD
Polythiazide—Agitation—Doxorubicin—testicular cancer	0.00252	0.00252	CcSEcCtD
Polythiazide—Vertigo—Doxorubicin—testicular cancer	0.00247	0.00247	CcSEcCtD
Polythiazide—Anorexia—Methotrexate—testicular cancer	0.00247	0.00247	CcSEcCtD
Polythiazide—Leukopenia—Doxorubicin—testicular cancer	0.00246	0.00246	CcSEcCtD
Polythiazide—Thrombocytopenia—Epirubicin—testicular cancer	0.00237	0.00237	CcSEcCtD
Polythiazide—Paraesthesia—Methotrexate—testicular cancer	0.00232	0.00232	CcSEcCtD
Polythiazide—Anorexia—Epirubicin—testicular cancer	0.00231	0.00231	CcSEcCtD
Polythiazide—Decreased appetite—Methotrexate—testicular cancer	0.00225	0.00225	CcSEcCtD
Polythiazide—Thrombocytopenia—Doxorubicin—testicular cancer	0.00219	0.00219	CcSEcCtD
Polythiazide—Paraesthesia—Epirubicin—testicular cancer	0.00218	0.00218	CcSEcCtD
Polythiazide—Anorexia—Doxorubicin—testicular cancer	0.00214	0.00214	CcSEcCtD
Polythiazide—Decreased appetite—Epirubicin—testicular cancer	0.00211	0.00211	CcSEcCtD
Polythiazide—Constipation—Epirubicin—testicular cancer	0.00207	0.00207	CcSEcCtD
Polythiazide—Urticaria—Methotrexate—testicular cancer	0.00206	0.00206	CcSEcCtD
Polythiazide—Paraesthesia—Doxorubicin—testicular cancer	0.00201	0.00201	CcSEcCtD
Polythiazide—Decreased appetite—Doxorubicin—testicular cancer	0.00195	0.00195	CcSEcCtD
Polythiazide—Urticaria—Epirubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Polythiazide—Constipation—Doxorubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Polythiazide—Hypersensitivity—Methotrexate—testicular cancer	0.00191	0.00191	CcSEcCtD
Polythiazide—Asthenia—Methotrexate—testicular cancer	0.00186	0.00186	CcSEcCtD
Polythiazide—Hypersensitivity—Epirubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Polythiazide—Urticaria—Doxorubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Polythiazide—Diarrhoea—Methotrexate—testicular cancer	0.00177	0.00177	CcSEcCtD
Polythiazide—Asthenia—Epirubicin—testicular cancer	0.00174	0.00174	CcSEcCtD
Polythiazide—Dizziness—Methotrexate—testicular cancer	0.00171	0.00171	CcSEcCtD
Polythiazide—Diarrhoea—Epirubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Polythiazide—Hypersensitivity—Doxorubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Polythiazide—Vomiting—Methotrexate—testicular cancer	0.00165	0.00165	CcSEcCtD
Polythiazide—Rash—Methotrexate—testicular cancer	0.00163	0.00163	CcSEcCtD
Polythiazide—Dermatitis—Methotrexate—testicular cancer	0.00163	0.00163	CcSEcCtD
Polythiazide—Headache—Methotrexate—testicular cancer	0.00162	0.00162	CcSEcCtD
Polythiazide—Asthenia—Doxorubicin—testicular cancer	0.00161	0.00161	CcSEcCtD
Polythiazide—Dizziness—Epirubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Polythiazide—Vomiting—Epirubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Polythiazide—Nausea—Methotrexate—testicular cancer	0.00154	0.00154	CcSEcCtD
Polythiazide—Diarrhoea—Doxorubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Polythiazide—Rash—Epirubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Polythiazide—Dermatitis—Epirubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Polythiazide—Headache—Epirubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Polythiazide—Dizziness—Doxorubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Polythiazide—Nausea—Epirubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Polythiazide—Vomiting—Doxorubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Polythiazide—Rash—Doxorubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Polythiazide—Dermatitis—Doxorubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Polythiazide—Headache—Doxorubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Polythiazide—Nausea—Doxorubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
